My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Felvizumab Biosimilar, RSV Monoclonal Antibody

Felvizumab Biosimilar, RSV Monoclonal Antibody

respiratory syncytial virus

Catalog No. Product Name Size List Price (US$) Quantity
C047P Felvizumab Biosimilar, RSV Monoclonal Antibody 1 mg 250.00
C047P Felvizumab Biosimilar, RSV Monoclonal Antibody 5 mg 750.00
C047P Felvizumab Biosimilar, RSV Monoclonal Antibody 20 mg 2000.00
Description

C047P: Felvizumab Biosimilar, RSV Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Isotype: Human IgG1 kappa.
Source: The anti-human Respiratory Syncytial Virus (RSV) monoclonal antibody felvizumab biosimilar was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade felvizumab biosimilar specifically binds to the human Respiratory Syncytial Virus.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by felvizumab.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: <1 EU/mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The research grade felvizumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Background

Felvizumab Biosimilar uses the same protein sequences as the therapeutic antibody felvizumab.

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.

Syd Labs also provides the following Anti-Respiratory Syncytial Virus (anti-RSV) antibody biosimilar proteins:
Palivizumab Biosimilar, research grade, anti-human RSV monoclonal antibody

Related Links

See our Privacy Policy